Genus PLC (GNS)

Currency in GBP
2,575.2
+5.2(+0.20%)
Real-time Data·
GNS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2,540.02,580.0
52 wk Range
1,424.03,220.0
Key Statistics
Bid/Ask
2,560.00 / 2,580.00
Prev. Close
2,570
Open
2,540
Day's Range
2,540-2,580
52 wk Range
1,424-3,220
Volume
673
Average Volume (3m)
150.91K
1-Year Change
69.08%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GNS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
2,980.6
Upside
+15.74%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth

Genus PLC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Genus Company Profile

Genus plc produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It offers dairy and beef bull semen and embryos under the Genus and Bovec brands; breeding pork and semen, as well as technical services and advice under the PIC brand. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.

Compare GNS to Peers and Sector

Metrics to compare
GNS
Peers
Sector
Relationship
P/E Ratio
89.1x−5.0x−0.6x
PEG Ratio
0.62−0.070.00
Price/Book
3.6x4.4x2.6x
Price / LTM Sales
2.6x6.1x3.2x
Upside (Analyst Target)
16.7%113.1%41.8%
Fair Value Upside
Unlock−5.3%5.1%Unlock

Analyst Ratings

8 Buy
1 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 2,980.6
(+15.74% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Berenberg
Buy30.50+18.49%-New Coverage26/11/2025
Deutsche Bank
Buy31.00+20.44%29.00Maintain20/11/2025
Stifel
Hold23.00-10.64%18.50Maintain09/09/2025
Kepler Cheuvreux
Hold27.00+4.90%20.75Downgrade05/09/2025
Deutsche Bank
Buy25.50-0.93%22.50Maintain16/07/2025

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.29%
Dividend Yield
1.25%
Industry Median 0.97%
Annualised payout
32.00
Paid unevenly
5-Years Growth
+1.92%
Growth Streak

Earnings

Latest Release
Oct 10, 2025
EPS / Forecast
0.26 / --
Revenue / Forecast
336.40M / --
EPS Revisions
Last 90 days

Genus (GNS) Income Statement & Profits

People Also Watch

465.00
VOF
-0.43%
371.00
ZIG
-1.85%
3,897.6
FOUR
+0.45%
163.80
ITH
-0.12%
1,671.43
KLR
+0.09%

FAQ

What Is the Genus (GNS) Share Price Today?

The live Genus share price today is 2,575.2

What Stock Exchange Does Genus (GNS) Trade On?

Genus is listed and trades on the London Stock Exchange.

What Is the Ticker (Stock Symbol) for Genus?

The stock symbol (also called a 'ticker') for Genus is "GNS."

Does Genus Pay Dividends? What’s The Current GNS Dividend Yield?

Yes, GNS Pays Dividends to its Shareholders. The current Genus dividend yield is 1.25%.

What Is the Current Genus Market Cap?

As of today, Genus market capitalisation is 1.72B.

What Is Genus's (GNS) Earnings Per Share (TTM)?

The Genus EPS is currently 0.29 (Trailing Twelve Months).

When Is the Next Genus Earnings Date?

Genus's next earnings report will be released on 26 Feb 2026.

Is GNS a Buy or Sell From a Technical Analyst Perspective?

Based on today's Genus moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Genus Stock Split?

Genus has split 0 times. (See the GNS stock split history page for full effective split date and price information.)

How Many Employees Does Genus Have?

Genus has 3190 employees.

What is the current trading status of Genus (GNS)?

As of 24 Dec 2025, Genus (GNS) is trading at a price of 2,575.2, with a previous close of 2,570.0. The stock has fluctuated within a day range of 2,540.0 to 2,580.0, while its 52-week range spans from 1,424.0 to 3,220.0.

What Is Genus (GNS) Price Target According to Analysts?

The average 12-month price target for Genus is GBP2980.556, with a high estimate of GBP3500 and a low estimate of GBP2400. 8 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +15.74% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.